TITLE

A caveat for thrombolytic treatment of stroke?

AUTHOR(S)
Jolobe, Oscar
PUB. DATE
August 2013
SOURCE
British Journal of Hospital Medicine (17508460);Aug2013, Vol. 74 Issue 8, p475
SOURCE TYPE
Academic Journal
DOC. TYPE
Letter
ABSTRACT
A letter to the editor is presented in response to articles in previous issues related to CNS tuberculosis and infective endocarditis.
ACCESSION #
89798472

 

Related Articles

  • Chemotherapy and the tumor microenvironment: the contribution of circulating endothelial cells. Francesco Bertolini // Cancer & Metastasis Reviews;Mar2008, Vol. 27 Issue 1, p95 

    Abstract  Anti-angiogenic drugs, alone or in combination with chemotherapeutics, are increasingly used by medical oncologists. In many cases, however, their mechanism of action and the tailoring of optimal dosage/schedule are still elusive. Circulating endothelial cell (CEC) and progenitor...

  • Clinical biomarkers of kinase activity: examples from EGFR inhibition trials. Mechthild Krause; Michael Baumann // Cancer & Metastasis Reviews;Sep2008, Vol. 27 Issue 3, p387 

    Abstract Introduction  Tumor response and duration of patient survival after treatment with inhibitors of the epidermal growth factor receptor (EGFR) varies considerably between different kinds of EGFR inhibitors, different combination schedules, but also between individual patients. ...

  • Journal of Thoracic Oncology: CYFRA21-1 might be predictive marker in advanced NSCLC.  // Biomedical Market Newsletter;3/21/2012, Vol. 21, p1 

    The article presents information on CYFRA, a biomarker, which was found suitable in chemotherapy for nonsmall cell lung cancer (NSCLC).

  • Journal of Proteomics: Biomarker family found for chemo resistant breast cancers.  // Biomedical Market Newsletter;4/14/2012, Vol. 21, p1 

    The article informs that scientists from the University of Hull, Hull, England have discovered biomarkers which could help to predict resistance to chemotherapy in breast cancer patients.

  • In early breast cancer, who does not need chemo? The hunt for prognostic markers. McNeil, Caroline // JNCI: Journal of the National Cancer Institute;11/04/98, Vol. 90 Issue 21, p1594 

    Focuses on the efforts to find prognostic markers for breast cancer patients who do not need chemotherapy. Criteria for subjecting patients to chemotherapy; Research on biomarkers for breast cancer.

  • Expression analysis of genes associated with human osteosarcoma tumors shows correlation of RUNX2 overexpression with poor response to chemotherapy. Sadikovic, Bekim; Thorner, Paul; Chilton-MacNeill, Susan; Martin, Jeff W.; Cervigne, Nilva K.; Squire, Jeremy; Zielenska, Maria // BMC Cancer;2010, Vol. 10, p202 

    Background: Human osteosarcoma is the most common pediatric bone tumor. There is limited understanding of the molecular mechanisms underlying osteosarcoma oncogenesis, and a lack of good diagnostic as well as prognostic clinical markers for this disease. Recent discoveries have highlighted a...

  • Blood biomarkers role in acute ischemic stroke patients: higher is worse or better? Kisialiou, Aliaksei; Pelone, Giordana; Carrizzo, Albino; Grillea, Giovanni; Trimarco, Valentina; Marino, Marina; Bartolo, Michelangelo; De Nunzio, Alessandro Marco; Grella, Rodolfo; Landolfi, Alessandro; Puca, Annibale; Colonnese, Claudio; Vecchione, Carmine // Immunity & Ageing;2012, Vol. 9, p22 

    Background: Thrombolytic therapy (TT) for acute ischemic stroke (AIS) can provoke bleeding's complication depending on the ischemic lesion (IL) dimension. Inflammation involved in the setting of acute ischaemic stroke, is associated with infarct size. We aimed to study the independent...

  • Circulating miR-30a, miR-126 and let-7b as biomarker for ischemic stroke in humans. Guangwen Long; Feng Wang; Huaping Li; Zhongwei Yin; Chaugai Sandip; Yan Lou; Yan Wang; Chen Chen; Dao Wen Wang // BMC Neurology;2013, Vol. 13 Issue 1, p1 

    Background Recently, plasma miRNAs have been reported as biomarkers for various diseases. However, the knowledge on the association of plasma miRNAs with ischemic stroke is still lacking. In this study, we investigated weather plasma concentrations of miR-30a, miR-126 and let-7b may be...

  • Serum IL-33 Is a Novel Diagnostic and Prognostic Biomarker in Acute Ischemic Stroke. Qian Li; Yuanshao Lin; Wensi Huang; Yulei Zhou; Xiaoli Chen; Brian Wang; Wanli Zhang; Zhengyi Cai; Jie Xue; Wenhui Zhang; Tieer Yu; Hong Wang; Jincai He; Kunlin Jin; Bei Shao // Aging & Disease;Oct2016, Vol. 7 Issue 5, p614 

    Interleukin-33 (IL-33), a newly recognized IL-1 family member, is expressed in various tissues and cells, and involved in pathogenesis of many human diseases. For example, IL-33 plays a protective role in cardiovascular diseases. However, the role of IL-33 in acute ischemic stroke (AIS) remains...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics